The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone
about
Dapsone in dermatology and beyondMMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex.An evaluation of dapsone gel 5% in the treatment of acne vulgaris.The role of inflammation in the pathology of acne.Epidermolysis bullosa acquisita in a 17-year-old boy with Crohn's disease.Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8Mucosal disease series. Number III. Mucous membrane pemphigoid.Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectivenessWhy dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma.Epidermolysis bullosa acquisita.Oral inflammation, a role for antimicrobial peptide modulation of cytokine and chemokine responses.Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity.Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.Calcitriol exerts anti-inflammatory effects in keratinocytes treated with autoantibodies from a patient with bullous pemphigoid.Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid.A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash.An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
P2860
Q34390020-4B102813-1A0D-4383-A34A-50D5F788AE4DQ34875505-71889BA3-1014-4ACD-8E82-F6E41ABEE9E0Q34985540-DB27CDBD-51F4-441F-858F-B86B1AA77C15Q34996121-8E7BDAD7-E960-4669-AE63-AF195C6C015AQ35844325-05DFD0DB-40D9-4CDB-AD00-950D953E48E0Q36090714-32F3969D-AA97-4C7F-B3A4-DFFE69C5ABD1Q36177681-3F84BBB3-F19E-44AC-92FC-67879E8987EFQ36234132-5DB78BC1-9166-4BA7-A682-CC88C9148A11Q38007011-05289860-9B61-42A7-9BE4-5D87759709C4Q38078021-6E3BE696-76CF-478B-94E7-BE20976BC596Q38152470-191C1346-DBC8-48F5-BB43-65FDC00B47C8Q38811369-5FE72502-3F44-4A35-889F-38571CCD64D3Q38891976-F6549037-688B-4533-A5F6-124FB7ED53A6Q38998547-9089C53B-35B3-4D42-876E-CBD26BD83C7BQ41544954-2CBF15F6-19EE-4F63-B404-906A5EFA318FQ46244822-26BAFF7A-4B83-46E3-8741-2A21288422EFQ47553901-96C05B34-8BA9-40E7-972A-CF7DE4973A73Q48157175-8FA72047-DDA1-44BC-9C7D-E112DB86FB5D
P2860
The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@ast
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@en
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@nl
type
label
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@ast
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@en
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@nl
prefLabel
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@ast
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@en
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@nl
P2093
P2860
P1476
The IL-8 release from cultured ...... n 180, is inhibited by dapsone
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.2001.01503.X
P407
P50
P577
2001-04-01T00:00:00Z